About Dr Peter Kay…
CURRICULUM VITAE
Dr. Peter Hamilton Kay
Address: 80 Evandale Street, Floreat,Western Australia, 6014
Phone: +61 (08) 9383 7577
Facsimile: +61 (08) 9387 6077
Email: Please use my contact form initially:
http://DrPKay.com/contact-peter/
Nationality: Australian citizen born in United Kingdom
Date of Birth: 4th April, 1945
Sex: Male
Retired: 2001
EMPLOYMENT:
1989 - 2001
Department of Pathology, The University of Western Australia,
Founder and Head of the Molecular Pathology Laboratory.
(Co-ordinator of Human Oncobiology third year undergraduate
course, Faculty of Science, The University of Western Australia).
1979-1988
Department of Pathology, The University of Western Australia,
Scientist.
1974-1978
Department of Clinical Immunology, Royal Perth Hospital,
Lecturer/Scientist.
1965-1973
Blood Transfusion Centre, Lancaster UK,
Scientist
Qualifications: Ph.D, FIMLS
Affiliations: International Society for Animal Genetics
Director of Research, Hybrid Biosciences Pty. Ltd.
MEMBER OF GRANT APPLICATION ASSESSMENT PANEL FOR:-
i. National Health and Medical Research Council of Australia.
Current Since 1988
ii. Health Research Council of New Zealand.
Current Since 1992
iii. Anti-Cancer Council of Victoria.
Current Since 1990
iv. Anti-Cancer Foundation of South Australia.
Current Since 1993
MAJOR PERSONAL COMPETITIVE GRANTS AWARDED:
1990-2000 In excess of $600,000
POST-GRADUATE STUDENTS SUPERVISED (1994-2006):
PhD J Taylor (passed)
M Franchina (passed)
S Marlow (passed)
D Lynch (passed)
T Butler (passed)
J Pelham (current)
M.Sc M Pavlovich (passed)
B.Sc Hons M Ahmed (passed)
D Paisley (passed)
B Shannon (passed)
M Franchina (passed)
A Thompson (passed)
N Suraweera (passed)
J Pini (passed)
E King (passed)
J Manski-Mankervis (passed)
M Cruickshank (passed)
Grad. Diploma A Wholley (passed)
POST DOCTORAL SUPERVISION/TRAINING:
Dr. A. Bagwe (Supported by the Biotechnology Department
of Government of India for post-doctoral
cancer research training, 1997 - 1998).
PATENTS:
Original Inventor and Author of PATENT (U.S. Patent Application 09/920000) entitled “Use of fluorescent molecular beacons in the detection of methylated nucleic acids”.
Original Inventor and Author of PATENT (International Patent Application No.PCT/AU2005/000141) entitled “Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof”.
INVITED REVIEWS:
Kay PH, Spagnolo DV, Taylor JME, Ziman M. DNA methylation and developmental genes in lymphomagenesis - more questions than answers? Leukemia Lymphoma 24:211-220 (1997).
Kay PH, Jacobsen PF, Taylor J, Spagnolo DV. The significance of DNA methylation in cancer. Adv Anat Path 2:353-361 (1995).
Kay PH, Papadimitriou JM. What’s new in the role of complement in disease? Path Res Pract 186:410-414 (1990)
INVITED CHAPTER IN BOOK:
Taylor JME, Kay PH, Spagnolo DV. The diagnostic and prognostic significance of the methylation status of Myf-3 in lymphoproliferative disorders. In: Molecular Diagnosis of Cancer. Eds. J.Bartlett, J. Roulston. Humana Press, Totowa (2002).
Kay PH, Dawkins RL. Complement genetics and disease. In : Complement in Health and Disease. Ed. K. Whaley. MTP Press, Lancaster, 1986.
DIRECTORSHIPS:
Director, Research & Development, Hooflon International Pty Ltd